The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultation document about its safety and efficacy. This has been issued for four weeks’ ...

An extravascular ICD with a substernal lead might retain the benefits, and avoid the risks, of transvenous and subcutaneous ICDs, but data on safety and efficacy are needed. New research findings are ...

Boston Scientific has begun a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable cardioverter defibrillator—two separate devices ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study.

Evera MRI ICD System Approved for Use During Full Body MRI Scans for Patients at Risk of Sudden Cardiac Arrest DUBLIN - Sept. 14, 2015 - Medtronic plc today announced that it has received the first ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter ...

Sudden cardiac death is commonly caused by ventricular arrhythmias, which may be an abnormally fast heartbeat (ventricular tachycardia) or an irregular rhythm (ventricular fibrillation). The most ...

In a prospective global study, extravascular implantable cardioverter–defibrillators with a substernal lead were implanted safely and were able to detect and terminate induced ventricular arrhythmias ...